Herpesvirus Antiviral Resistance
Database


    • TOP

    Hartline CB

    Mutations:

    Mutant Gene Virus Reference
    D542E UL54 Human betaherpesvirus 5 Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. (Jul 2013)
    D542E UL54 Human betaherpesvirus 5 Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. (Jul 2013)
    D542E UL54 Human betaherpesvirus 5 Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus. (Jul 2013)
    D456N UL97 Human betaherpesvirus 5 Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions. ( 2014)
    D456N UL97 Human betaherpesvirus 5 Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions. ( 2014)
    C480R UL97 Human betaherpesvirus 5 Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions. ( 2014)
    C480R UL97 Human betaherpesvirus 5 Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions. ( 2014)
    Y617del UL97 Human betaherpesvirus 5 Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions. ( 2014)
    Y617del UL97 Human betaherpesvirus 5 Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions. ( 2014)